News

According to a research conducted by a group of scientists in partnership with professor Michael Krainer, director of the molecular genetics working group, department of oncology, University Clinic

Earlier, COTI had entered into this partnership to advance its HIV-1 integrase inhibitor program. As per the agreement, COTI retains all data and intellectual property ownership of the

Prograf is prescribed to prevent organ rejection in patients receiving allogenic liver, kidney, or heart transplants and was first approved and launched in Japan in 1993. Prograf is

Further to the addition of the new drug delivery system, the company has named Edgar Jaynes as its associate director of pharmaceutical development services. Dr Jaynes comes to

As per the agreement, the parties are expected to evaluate the potential utility of RXi’s proprietary rxRNA technology against specific miRNA targets of interest to miRagen in the

Ferenc Darvas, founder and president of board at NanGenex, said: “This is a major milestone in the development of a new class of innovative Nanodrugs that provide fundamental

Metabolex is expected to work with TSF on the evaluation and validation of protein targets for the development of biological products. Metabolex will provide novel protein targets discovered

Sanofi reportedly made an investment of $90m to enhance capacity at its manufacturing facility in Beijing in April 2009, which according to Chris Viehbacher, CEO of the company,

LOR-253 is a small molecule compound that has shown selective and potent antitumor activity in a variety of human cancers, including colon cancer and non-small cell lung cancer,